Trial intelligence / Profile preview

Fibrin Sealant in Harmonic Scalpel-assisted Thyroidectomy

NCT01126060Phase 3Completed

Sponsor
Samsung Medical Center
Start
Feb 2010
Primary completion
Jan 2011
Modality
Biologic
Countries
1
01

Overview

Phase 3, randomised, open-label trial of porcine fibrin sealant in thyroid carcinoma (TC) (2 arms), sponsored by Samsung Medical Center. Primary endpoint: Postoperative Drainage Amount at 4 days. Started Feb 2010; status: completed.

02

Drugs

porcine fibrin sealant
03

Conditions

thyroid carcinoma (TC)

Beyond the preview

Go deeper on NCT01126060.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01126060.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call